US drug industry's claims of other countries “freeloading” are a mythBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7484.165 (Published 20 January 2005) Cite this as: BMJ 2005;330:165
- Ray Moynihan
A member of George Bush's Presidential Business Commission—a group of business and professional people who are advising the president on the next election—has launched a scathing attack on the US pharmaceutical industry and on the industry's claims that other countries are damaging drug development by paying lower prices.
Delivering the David Rogers lecture at Cornell Medical College in New York last month, bioethicist Donald Light said no evidence existed to support the view that European nations were “freeloading” and that the current US attempts to raise prices through free-trade agreements with other countries were simply designed to boost profits, not …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial